TTC CO LTD has a total of 16 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are GENTERIC INC, CHS PHARMA INC and THE MEDICINES CO.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Enzymes | |
#5 | Peptides | |
#6 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Hasumi Keiji | 9 |
#2 | Shimizu Kosuke | 9 |
#3 | Yamamoto Tetsuro | 5 |
#4 | Kobayashi Takeshi | 4 |
#5 | Honda Hiroyuki | 4 |
#6 | Shinkai Masashige | 2 |
#7 | Ohtsuka Kenzo | 2 |
#8 | Ito Akira | 2 |
#9 | Shimomitsu Teruichi | 1 |
#10 | Ueno Kengo | 1 |
Publication | Filing date | Title |
---|---|---|
US7282479B2 | Hyperthermia agent for malignant tumor comprising cytokine and magnetic fine particles | |
CA2557154A1 | Anticancer agent containing bl-angiostatin | |
KR20050095608A | Affinity trap reactor and single-step process for purifying angiostatin-like fragment from human plasma using the same | |
CA2512894A1 | Affinity trap reactor and single-step process for purifying angiostatin-like fragment from human plasma using the same | |
EP1438971A1 | Immunopotentiators in thermotherapy for cancer | |
WO03016346A1 | Ligands |